Opportunity
Simpler Grants.gov #PAR-25-383
NIH Blueprint MedTech Translator Funding for Device Development and Clinical Translation
Buyer
National Institutes of Health
Posted
June 17, 2025
Respond By
January 28, 2028
Identifier
PAR-25-383
NAICS
541715, 541714, 541713
This opportunity from the National Institutes of Health (NIH) seeks applications for the Blueprint MedTech Translator program, focused on advancing therapeutic and diagnostic devices for nervous or neuromuscular system disorders. - Government Buyer: - National Institutes of Health (NIH) - Products/Services Requested: - Translational and clinical feasibility studies for medical devices - Includes prototype device implementation - Non-clinical safety and efficacy testing - Design verification and validation - Regulatory approvals (IDE, IRB) - Clinical feasibility studies - OEMs and Vendors: - No specific OEMs or vendors named; open to all eligible applicants, including those developing their own devices or collaborating with manufacturers - Unique/Notable Requirements: - Milestone-driven cooperative agreement with NIH oversight - Access to NIH-funded consultants and contract research organizations for specialized testing and manufacturing - Broad eligibility: individuals, institutions, businesses, and other entities - Devices must target disorders of the nervous or neuromuscular systems
Description
This funding opportunity encourages investigators to pursue translational activities and clinical feasibility studies to advance the development of therapeutic and diagnostic devices for nervous or neuromuscular system disorders. Supported activities include clinical prototype implementation, non-clinical safety and efficacy testing, design verification and validation, obtaining IDE or IRB approvals, and clinical feasibility studies. The program is milestone-driven and involves NIH program staff participation, collaboration with NIH-funded consultants, and access to NIH contract research organizations. Eligible applicants include a wide range of educational, nonprofit, government, business, and miscellaneous entities.